CD27 and CD70 do not play a critical role in the development of experimental allergic conjunctivitis in mice.

[1]  W. Shreffler.  CD137-Mediated Immunotherapy for Allergic Asthma , 2007, Pediatrics.

[2]  T. Polte,et al.  CD137 ligand prevents the development of T‐helper type 2 cell‐mediated allergic asthma by interferon‐γ‐producing CD8+ T cells , 2007, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[3]  K. Fukuda,et al.  Differential contributions of B7-1 and B7-2 to the development of murine experimental allergic conjunctivitis. , 2007, Immunology letters.

[4]  M. Azuma,et al.  Involvement of programmed death-ligand 2 (PD-L2) in the development of experimental allergic conjunctivitis in mice , 2006, British Journal of Ophthalmology.

[5]  S. Burdach,et al.  CD137-mediated immunotherapy for allergic asthma. , 2006, The Journal of clinical investigation.

[6]  Tomoko Yamaguchi,et al.  Roles of OX40 in the development of murine experimental allergic conjunctivitis: exacerbation and attenuation by stimulation and blocking of OX40. , 2006, Investigative ophthalmology & visual science.

[7]  Fu-Tong Liu,et al.  Genetic background determines susceptibility to experimental immune-mediated blepharoconjunctivitis: comparison of Balb/c and C57BL/6 mice. , 2006, Experimental eye research.

[8]  Tomoko Yamaguchi,et al.  The interaction between ICOS and B7RP-1 is not required for the development of experimental murine allergic conjunctivitis. , 2005, Biochemical and biophysical research communications.

[9]  M. Kubo,et al.  The Control of Allergic Conjunctivitis by Suppressor of Cytokine Signaling (SOCS)3 and SOCS5 in a Murine Model1 , 2005, The Journal of Immunology.

[10]  Tomoko Yamaguchi,et al.  Engagement of 4-1BB Inhibits the Development of Experimental Allergic Conjunctivitis in Mice1 , 2005, The Journal of Immunology.

[11]  J. Borst,et al.  CD27 Promotes Survival of Activated T Cells and Complements CD28 in Generation and Establishment of the Effector T Cell Pool , 2003, The Journal of experimental medicine.

[12]  M. Croft,et al.  OX40 (CD134) Controls Memory T Helper 2 Cells that Drive Lung Inflammation , 2003, The Journal of experimental medicine.

[13]  K. Sugamura,et al.  Critical role for OX40 ligand in the development of pathogenic Th2 cells in a murine model of asthma , 2003, European journal of immunology.

[14]  A. Kampik,et al.  Toxic eosinophil granule protein deposition in corneal ulcerations and scars associated with atopic keratoconjunctivitis. , 2002, American journal of ophthalmology.

[15]  A. Sharpe,et al.  Costimulatory molecule OX40L is critical for both Th1 and Th2 responses in allergic inflammation , 2002, European journal of immunology.

[16]  R. V. van Lier,et al.  Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFNgamma-mediated B cell depletion. , 2001, Immunity.

[17]  M. Croft,et al.  Development of Allergic Inflammation in a Murine Model of Asthma Is Dependent on the Costimulatory Receptor Ox40 , 2001, The Journal of experimental medicine.

[18]  T. Schumacher,et al.  CD27 is required for generation and long-term maintenance of T cell immunity , 2000, Nature Immunology.

[19]  K. Okumura,et al.  Involvement of CD70–CD27 interactions in the induction of experimental autoimmune encephalomyelitis , 2000, Journal of Neuroimmunology.

[20]  K. Tsubota,et al.  Presence of eotaxin in tears of patients with atopic keratoconjunctivitis with severe corneal damage. , 1999, The Journal of allergy and clinical immunology.

[21]  N. Copeland,et al.  Characterization of murine CD70 by molecular cloning and mAb. , 1998, International immunology.

[22]  R. V. van Lier,et al.  Engagement of CD27 with its ligand CD70 provides a second signal for T cell activation. , 1995, Journal of immunology.

[23]  T. Watts,et al.  TNF/TNFR family members in costimulation of T cell responses. , 2005, Annual review of immunology.

[24]  O. Yoshida,et al.  Genetic background determines the nature of immune responses and experimental immune-mediated blepharoconjunctivitis (EC). , 1999, Current eye research.